CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing and commercializing additive printing technology for cell-based analysis systems. It aims to create scalable, cost-effective models for evaluating materials in industries such as pharmaceuticals and healthcare, enhancing predictive analysis capabilities.
The Project will develop and commercialise the additive printing of cell-based analysis systems.
The objective is to deliver consistent, scalable manufacturing of cell-based models used by multiple industry sectors to evaluate materials ranging from new drugs to healthcare products and functional foods.
The target market is global and growing (CAGR 12%; estimated $4.2Bn in 2016).
Additive printing will have positive disruptive impact, automating assay assembly and producing complex models needed…
AvantiCell Science Ltd
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
